THE PSYCHOPHYSIOLOGY OF ANXIETY
- 1 December 1964
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 139 (6) , 558-568
- https://doi.org/10.1097/00005053-196412000-00009
Abstract
The recent and remote literature on the psychophysiology of anxiety was reviewed and re-evaluated on the basis of recent advances in clinical and experimental psychiatry, physiology and learning theory. Operational hypotheses have been set forth relating the experimental data to the clinical phenomena, with special attention to the role of epinephrine. The first section reviewed the evidence that anxiety responses produce a relatively higher proportion of epinephrine than norepinephrine from the adrenal medulla. The next section cited literature concerning the response of "normal" and "neurotic" subjects to the injection of epinephrine. Apparently conflicting data are accounted for by 2 variables: first, the strength of the subject''s previously learned association between acute anxiety and sympathomimetic symptoms, and second, the degree of current anxiety reinforcement in the experimental setting. It was suggested that the sympathomimetic symptoms produced by epinephrine during anxiety further reinforce the individual''s anxiety, evoking a self-generating, spiraling anxiety reaction. A third section presented some very recent experiments which demonstrate sedative-like and parasympathetic effects following the systemic administration of epinephrine. It is postulated that epinephrine may function as a hormonal feedback mediator to the trophotropic function of the hypothalamus (Hess), producing the sedative-like and parasympathetic symptoms found in intense or prolonged anxiety. Thus the initial adrenal medullary secretion during anxiety may evoke sympathomimetic symptoms or cues which further reinforce the anxiety response, while more prolonged secretion may evoke parasympathetic and fatigue or sedative-like effects which compensate for the initial stages of the anxiety. Since epinephrine is a more prominent secretion in anxiety than in other responses, such as anger, and since it is more potent in producing sympathomimetic and subsequent sedative-like effects, epinephrine may account for many of the clinical phenomena characteristic of anxiety.Keywords
This publication has 10 references indexed in Scilit:
- Psychophysiological changes during infusions of adrenaline in various dosesPsychopharmacology, 1963
- Concurrent Plasma Epinephrine, Norepinephrine and 17-Hydroxycorticosteroid Levels During Conditioned Emotional Disturbances in MonkeysPsychosomatic Medicine, 1961
- PLASMA CONCENTRATIONS OF EPINEPHRINE AND NOREPINEPHRINE DURING INTRAVENOUS INFUSIONS IN MAN *†Journal of Clinical Investigation, 1959
- Selective Activation of Noradrenaline and Adrenaline Producing Cells in the Cat's Adrenal Gland by Hypothalamic StimulationCirculation Research, 1954
- Effect of Flying on the Epinephrine Excretion in Air Force PersonnelJournal of Applied Physiology, 1954
- Role of Adrenalin in Recovery of Inhibited Conditioned ReactionsExperimental Biology and Medicine, 1947
- Further studies in the use of adrenalin in the treatment of persistent anxiety statesPsychiatric Quarterly, 1945
- The Subjective Response of Psychoneurotic Patients to Adrenalin and Mecholyl (Acetyl-B-Methyl-Choline)*Psychosomatic Medicine, 1940
- THE EFFECTS OF ADRENALIN ON THE REFLEX EXCITABILITY OF THE AUTONOMIC NERVOUS SYSTEMAmerican Journal of Physiology-Legacy Content, 1939
- PHYSIOLOGIC EFFECTS OF ACETYL-BETA-METHYLCHOLINE (MECHOLYL) AND ITS RELATIONSHIP TO OTHER DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM.*The Lancet Healthy Longevity, 1937